Finance

Lists
Why is NURL down 33.33%?
Dive Deeper
NURL:CNSX
Neural Therapeutics Inc
CA$0.010
-33.33%
(-0.0050) 1D
Oct 23, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NURL...
Open
CA$0.01
High
CA$0.01
Low
CA$0.01
Mkt. cap
1.27M
Avg. vol.
4.06K
Volume
1.00K
52-wk high
CA$0.04
52-wk low
CA$0.01
EPS
-CA$0.01
Open
CA$0.01
High
CA$0.01
Low
CA$0.01
Mkt. cap
1.27M
Avg. vol.
4.06K
Volume
1.00K
52-wk high
CA$0.04
52-wk low
CA$0.01
EPS
-CA$0.01
News stories
From web sources and news partners
About Neural Therapeutics Inc
CEO-
Employees-
Founded2020
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Websiteneuraltherapeutics.ca
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.56K
4.80K
4.80K
4.80K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
236.20K
90.85K
50.65K
77.09K
Operating expense
247.76K
504.69K
55.45K
81.89K
Total operating expenses
247.76K
504.69K
55.45K
81.89K
Operating income
-247.76K
-504.69K
-55.45K
-81.89K
Other non operating income
-49.12K
-38.64K
-18.13K
-32.98K
EBT including unusual items
-981.74K
172.10K
-64.50K
-390.76K
EBT excluding unusual items
-297.14K
-544.57K
-64.50K
-390.76K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-981.74K
172.10K
-64.50K
-390.76K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps